Health
Researchers to test monoclonal antibodies against COVID-19 – Mirage News
Getty Images “We need a treatment that is effective,” said infectious disease physician Ann Collier, who is leading the trial at UW Medicine. UW…
UW Medicine is one of a network of U.S. sites testing a new treatment for COVID-19 that involves monoclonal antibodies, which are intended to provide immediate antiviral activity that lasts several weeks.
The drug is part of the ACTIV-2 Outpatient Monoclonal Antibodies and Other Therapies Trial, sponsored by the National Institute of Allergy and Infectious Diseases. The trial is also receiving support from Operation Warp Speed, the U.S. government’s multi-agency effort to help end the pandemic….
-
Business18 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
General23 hours agoBrick portico a relic of ‘prestigious’ Horton College in northern midlands
-
Noosa News13 hours agoRacing Queensland responds to criticism of ‘deadliest’ greyhound track
-
Noosa News20 hours agoQueenslanders to continue legal challenges against COVID-19 directives after successful appeal